EMA — authorised 5 November 2016
- Marketing authorisation holder: CSL Behring GmbH
- Status: approved
🇪🇺 Idelvion in European Union
EMA authorised Idelvion on 5 November 2016
Marketing authorisation
Idelvion in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in European Union
Frequently asked questions
Is Idelvion approved in European Union?
Yes. EMA authorised it on 5 November 2016.
Who is the marketing authorisation holder for Idelvion in European Union?
CSL Behring GmbH holds the EU marketing authorisation.